The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1007
August 15, 1997
View Complete Issue         Table of Contents 2019 
Bupropion (Zyban) for Smoking Cessation
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Bupropion (Zyban) for Smoking Cessation
August 15, 1997 (Issue: 1007)
Bupropion hydrochloride, currently available as an antidepressant (Wellbutrin - Medical Letter, 31:97, 1989; Wellbutrin SR), is now being marketed in a sustainedrelease formulation as Zyban (Glaxo Wellcome) for use as an aid in smoking...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Bupropion (Zyban) for Smoking Cessation
Article code: 1007a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.